Alpha Tau Medical (DRTS)
(Delayed Data from NSDQ)
$3.84 USD
-0.02 (-0.52%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $3.90 +0.06 (1.56%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
DRTS 3.84 -0.02(-0.52%)
Will DRTS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DRTS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for DRTS
The technical outlook for DRTS is unchanged after it rises 0.26% on September 16
DRTS forms Stochastic Reached Overbought on September 15
Is DRTS ready to make a move? Narrow Range Bar shows up after sliding 0.52%
DRTS forms Pocket Pivot on September 11
DRTS forms Slingshot Bullish on September 10